Disc Medicine, Inc. (IRON)

Disc Medicine Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	98.68	91.15	192.43	360.38	194.61	88.04
Short-Term Investments	619.07	700.01	297.45	-	-	-
Cash & Short-Term Investments	717.75	791.15	489.88	360.38	194.61	88.04
Cash Growth	10.43%	61.50%	35.93%	85.18%	121.06%	240.89%
Prepaid Expenses	15.02	12.75	3.73	5.28	3.88	2.45
Total Current Assets	732.76	803.9	493.62	365.66	198.49	90.48
Property, Plant & Equipment	1.81	2.26	2.32	2.1	1.6	1.75
Long-Term Deferred Charges	0.4	0.6	0.6	-	-	-
Other Long-Term Assets	0.1	0.13	0.24	0.23	0.12	0.18
Total Assets	735.07	806.88	496.77	368	200.21	92.41

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	6.84	9.02	7.95	12.63	16.16	2.56
Accrued Expenses	23.21	27.01	15.24	8.15	6.11	4.1
Current Portion of Leases	0.32	0.61	0.13	0.67	0.31	0.32
Other Current Liabilities	-	-	-	-	-	6.45
Total Current Liabilities	30.36	36.64	23.32	21.44	22.58	13.42
Long-Term Debt	59.34	29.16	28.32	-	-	-
Long-Term Leases	1.21	1.25	1.55	1.44	1.03	1.33
Total Liabilities	90.91	67.05	53.19	22.88	23.61	14.76

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	0	0	0	0	0	-
Additional Paid-In Capital	1,279	1,249	741.3	533.76	288.81	1.19
Retained Earnings	-633.22	-510.19	-298	-188.65	-112.22	-65.39
Comprehensive Income & Other	-1.61	0.97	0.29	-	-	-
Total Common Equity	644.16	739.83	443.59	345.12	176.6	-64.2
Shareholders' Equity	644.16	739.83	443.59	345.12	176.6	77.65
Total Liabilities & Equity	735.07	806.88	496.77	368	200.21	92.41

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	60.86	31.02	30	2.1	1.33	1.65
Net Cash (Debt)	656.88	760.13	459.88	358.28	193.28	86.38
Net Cash Growth	6.11%	65.29%	28.36%	85.37%	123.74%	248.66%
Net Cash Per Share	17.52	21.54	16.66	16.05	185.93	98.34
Filing Date Shares Outstanding	38.39	38.16	34.57	24.68	19	8.3
Total Common Shares Outstanding	38.35	37.89	29.87	24.36	17.4	8.3
Working Capital	702.4	767.26	470.3	344.22	175.91	77.06
Book Value Per Share	16.80	19.53	14.85	14.17	10.15	-7.74
Tangible Book Value	644.16	739.83	443.59	345.12	176.6	-64.2
Tangible Book Value Per Share	16.80	19.53	14.85	14.17	10.15	-7.74
Machinery	-	-	-	0.42	0.31	0.16

SEC Filings: 10-K · 10-Q

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Aug 26, 2026

Data Sources Report a data error